Orally Formulated Artemisinin in Healthy Fasting Vietnamese Male Subjects: A Randomized, Four-Sequence, Open-Label, Pharmacokinetic Crossover Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Orally Formulated Artemisinin in Healthy Fasting Vietnamese Male Subjects: A Randomized, Four-Sequence, Open-Label, Pharmacokinetic Crossover Study

Published:2011-05 Issue:5 Volume:33 Page:644-654
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Hien Tran Tinh,Hanpithakpong Warunee,Truong Nguyen Thanh,Dung Nguyen Thi,Toi Pham Van,Farrar Jeremy,Lindegardh Niklas,Tarning Joel,Ashton Michael

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference42 articles.

1. World Malaria Report 2008,2008

2. Artemisinin and its derivatives: an important new class of antimalarial agents;Balint;Pharmacology Ther,2001

3. Artemisinin resistance in Plasmodium falciparum malaria;Dondorp;N Engl J Med,2009

4. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia;Rogers;Malaria J,2009

5. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border;Alker;Am J Trop Med Hyg,2007

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic capability of five active compounds in typical African medicinal plants against main proteases of SARS-CoV-2 by computational approach;Informatics in Medicine Unlocked;2022

2. Anti-malarial drug: the emerging role of artemisinin and its derivatives in liver disease treatment;Chinese Medicine;2021-08-18

3. Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug;Frontiers in Pharmacology;2021-03-19

4. In vitro analyses of Artemisia extracts on Plasmodium falciparum suggest a complex antimalarial effect;PLOS ONE;2021-03-02

5. Targeting TGF-β pathway with COVID-19 Drug Candidate ARTIVeda/PulmoHeal Accelerates Recovery from Mild-Moderate COVID-19;2021-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3